CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 175 of 764 entries

View as:

Gestational Diabetes Monitoring and Management

Phase: N/A Priority: Normal

NCT ID: NCT06963528 Org: User:

Start: 12/01/21 End: 08/31/25 Due: 08/31/26

The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)

Phase: N/A Priority: Normal

NCT ID: NCT02354573 Org: User:

Start: 12/31/11 End: 01/31/14 Due: 01/31/15

Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination

Phase: N/A Priority: Normal

NCT ID: NCT02485912 Org: User:

Start: 07/31/15 End: 01/31/16 Due: 01/31/17

A Short CONSORT Checklist for Peer Reviewers to Improve the Reporting of Randomised Controlled Trials Published

Phase: N/A Priority: Normal

NCT ID: NCT05820971 Org: User:

Start: 06/15/19 End: 06/30/22 Due: 06/30/23

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Phase: N/A Priority: Normal

NCT ID: NCT04754776 Org: User:

Start: 06/11/21 End: 04/06/22 Due: 04/06/23

Extending the National Health Service (NHS) Breast Screening Age Range

Phase: N/A Priority: Normal

NCT ID: NCT01081288 Org: User:

Start: 06/30/09 End: 12/31/26 Due: 12/31/27

Imaging Intravenous Iron

Phase: N/A Priority: Normal

NCT ID: NCT05609318 Org: User:

Start: 10/29/22 End: 12/31/25 Due: 12/31/26

Effects of Seven Day Prucalopride Administration in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT03572790 Org: User:

Start: 06/11/18 End: 05/17/19 Due: 05/17/20

A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV

Phase: N/A Priority: Normal

NCT ID: NCT00731471 Org: User:

Start: 08/31/08 End: 01/31/11 Due: 01/31/12

Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria

Phase: N/A Priority: Normal

NCT ID: NCT02389439 Org: User:

Start: 03/01/15 End: 06/01/16 Due: 06/01/17

A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults

Phase: N/A Priority: Normal

NCT ID: NCT00993083 Org: User:

Start: 06/30/09 End: 03/31/10 Due: 03/31/11

Defining Circadian Metabolism in Non-alcoholic Fatty Liver Disease

Phase: N/A Priority: Normal

NCT ID: NCT05962099 Org: User:

Start: 03/01/21 End: 06/01/24 Due: 06/01/25

A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S

Phase: N/A Priority: Normal

NCT ID: NCT01883609 Org: User:

Start: 09/30/13 End: 08/31/14 Due: 08/31/15

Prucalopride and Cognition in Recovered Depression

Phase: N/A Priority: Normal

NCT ID: NCT05220228 Org: User:

Start: 01/04/22 End: 11/13/23 Due: 11/13/24

A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

Phase: N/A Priority: Normal

NCT ID: NCT05380388 Org: User:

Start: 12/01/25 End: 12/30/27 Due: 12/30/28

IMPROV (Improving the Radical Cure of Vivax Malaria)

Phase: N/A Priority: Normal

NCT ID: NCT01814683 Org: User:

Start: 07/31/14 End: 02/28/18 Due: 02/28/19

Effectiveness of 'Taking it Further' (TiF) Programme

Phase: N/A Priority: Normal

NCT ID: NCT05154266 Org: User:

Start: 06/28/21 End: 12/21/21 Due: 12/21/22

Effects of Bupropion in Depression

Phase: N/A Priority: Normal

NCT ID: NCT02104128 Org: User:

Start: 01/31/14 End: 05/31/16 Due: 05/31/17

Prospective Cohort for Early Detection of Liver Cancer

Phase: N/A Priority: Normal

NCT ID: NCT05541601 Org: User:

Start: 02/23/22 End: 07/31/37 Due: 07/31/38

The Efficacy of Viscosupplementation for Early Knee Osteoarthritis

Phase: N/A Priority: Normal

NCT ID: NCT01210742 Org: User:

Start: 05/31/11 End: 10/31/13 Due: 10/31/14

A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

Phase: N/A Priority: Normal

NCT ID: NCT03705234 Org: User:

Start: 10/30/18 End: 12/31/49 Due: 12/31/50

Iron Absorption and Requirements in Pregnancy and Lactation

Phase: N/A Priority: Normal

NCT ID: NCT05973552 Org: User:

Start: 07/31/23 End: 09/01/26 Due: 09/01/27

Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative

Phase: N/A Priority: Normal

NCT ID: NCT02625285 Org: User:

Start: 01/24/17 End: 01/31/18 Due: 01/31/19

KLH Challenge to Explore the Human Immune Response

Phase: N/A Priority: Normal

NCT ID: NCT05876195 Org: User:

Start: 03/01/23 End: 02/29/24 Due: 02/28/25

Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents

Phase: N/A Priority: Normal

NCT ID: NCT02178748 Org: User:

Start: 06/30/14 End: 01/31/15 Due: 01/31/16

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Gestational Diabetes Monitoring and Management	NCT06963528	University of Oxford	user2@example.com	None	2021-12-01	2025-08-31	2026-08-31	-	-	2025-07-14
The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)	NCT02354573	University of Oxford	user2@example.com	None	2011-12-31	2014-01-31	2015-01-31	-	-	2025-07-14
Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination	NCT02485912	University of Oxford	user2@example.com	None	2015-07-31	2016-01-31	2017-01-31	-	-	2025-07-14
A Short CONSORT Checklist for Peer Reviewers to Improve the Reporting of Randomised Controlled Trials Published	NCT05820971	University of Oxford	user2@example.com	None	2019-06-15	2022-06-30	2023-06-30	-	-	2025-07-14
Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)	NCT04754776	University of Oxford	user2@example.com	None	2021-06-11	2022-04-06	2023-04-06	-	-	2025-07-14
Extending the National Health Service (NHS) Breast Screening Age Range	NCT01081288	University of Oxford	user2@example.com	None	2009-06-30	2026-12-31	2027-12-31	-	-	2025-07-14
Imaging Intravenous Iron	NCT05609318	University of Oxford	user2@example.com	None	2022-10-29	2025-12-31	2026-12-31	-	-	2025-07-14
Effects of Seven Day Prucalopride Administration in Healthy Volunteers	NCT03572790	University of Oxford	user2@example.com	None	2018-06-11	2019-05-17	2020-05-17	-	-	2025-07-14
A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV	NCT00731471	University of Oxford	user2@example.com	None	2008-08-31	2011-01-31	2012-01-31	-	-	2025-07-14
Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria	NCT02389439	University of Oxford	user2@example.com	None	2015-03-01	2016-06-01	2017-06-01	-	-	2025-07-14
A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults	NCT00993083	University of Oxford	user2@example.com	None	2009-06-30	2010-03-31	2011-03-31	-	-	2025-07-14
Defining Circadian Metabolism in Non-alcoholic Fatty Liver Disease	NCT05962099	University of Oxford	user2@example.com	None	2021-03-01	2024-06-01	2025-06-01	-	-	2025-07-14
A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S	NCT01883609	University of Oxford	user2@example.com	None	2013-09-30	2014-08-31	2015-08-31	-	-	2025-07-14
Prucalopride and Cognition in Recovered Depression	NCT05220228	University of Oxford	user2@example.com	None	2022-01-04	2023-11-13	2024-11-13	-	-	2025-07-14
A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )	NCT05380388	University of Oxford	user2@example.com	None	2025-12-01	2027-12-30	2028-12-30	-	-	2025-07-14
IMPROV (Improving the Radical Cure of Vivax Malaria)	NCT01814683	University of Oxford	user2@example.com	None	2014-07-31	2018-02-28	2019-02-28	-	-	2025-07-14
Effectiveness of 'Taking it Further' (TiF) Programme	NCT05154266	University of Oxford	user2@example.com	None	2021-06-28	2021-12-21	2022-12-21	-	-	2025-07-14
Effects of Bupropion in Depression	NCT02104128	University of Oxford	user2@example.com	None	2014-01-31	2016-05-31	2017-05-31	-	-	2025-07-14
Prospective Cohort for Early Detection of Liver Cancer	NCT05541601	University of Oxford	user2@example.com	None	2022-02-23	2037-07-31	2038-07-31	-	-	2025-07-14
The Efficacy of Viscosupplementation for Early Knee Osteoarthritis	NCT01210742	University of Oxford	user2@example.com	None	2011-05-31	2013-10-31	2014-10-31	-	-	2025-07-14
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease	NCT03705234	University of Oxford	user2@example.com	None	2018-10-30	2049-12-31	2050-12-31	-	-	2025-07-14
Iron Absorption and Requirements in Pregnancy and Lactation	NCT05973552	University of Oxford	user2@example.com	None	2023-07-31	2026-09-01	2027-09-01	-	-	2025-07-14
Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative	NCT02625285	University of Oxford	user2@example.com	None	2017-01-24	2018-01-31	2019-01-31	-	-	2025-07-14
KLH Challenge to Explore the Human Immune Response	NCT05876195	University of Oxford	user2@example.com	None	2023-03-01	2024-02-29	2025-02-28	-	-	2025-07-14
Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents	NCT02178748	University of Oxford	user2@example.com	None	2014-06-30	2015-01-31	2016-01-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance